Jul 2
|
Asahi Kasei Pharma Starts Phase III Study of Promising CIPN Prevention Therapy, ART-123 (Recomodulin™), to Enhance Treatment Options Worldwide
|
May 19
|
Asahi Kasei Microdevices and Dirac Partner to Meet Growing Demand for High-Fidelity In-Car Audio Performance
|
May 14
|
Asahi Kasei Bioprocess America and PeptiSystems Announce Global Partnership in Peptide Manufacturing—Streamlining the Peptide Processing Market.
|
May 13
|
Asahi Kasei Receives Prestigious Okochi Memorial Prize for its Microcrystalline Cellulose (MCC) Ceolus™ UF Grade Used for Excipient in Tablets – Solving Tableting Issues, Improving Content Uniformity, and Achieving Challenging Dosage Form
|
Apr 8
|
Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward
|
Feb 25
|
Asahi Kasei Holds Grand Opening Ceremony for Biogas Purification System at Sewage Treatment Plant in Japan
|